Powering precision proteomics to enable to the earliest detection of disease.
Alamar Biosciences has raised $50.0M in total funding. The most recent round was Convertible Note. The last funding was announced in January 2026.
Alamar Biosciences's investors include Qiming Venture Partners, Samsara BioCapital, Sands Capital Ventures, Sherpa Healthcare Partners, Illumina Ventures.
Alamar Biosciences is headquartered in Fremont, United States.
Powering precision proteomics to enable to the earliest detection of disease.
Alamar Biosciences is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alamar Biosciences — Funding & Investors." VCBacked, January 11, 2026, https://www.vcbacked.co/company/alamar-biosciences. Accessed July 20, 2026.
VCBacked. (2026). Alamar Biosciences — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/alamar-biosciences
{{cite web |title=Alamar Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/alamar-biosciences |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated